Buprenorphine hemiadipate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBuprenorphine hemiadipate
Drug Alias NameRBP-6300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSwedenAustria +[4
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIndivior PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndivior Inc
Active IndicationsN/A
Inactive IndicationsOpioid-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A